跳至主要内容
临床试验/CTRI/2020/06/026117
CTRI/2020/06/026117尚未招募3 期

The usefulness of individualized Homoeopathy versus standard allopathic treatment in acute uncomplicated Urinary Tract Infection (UTI): A randomised comparative trial

Central Council for Research in Homoeopathy3 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2020年7月30日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
80
试验地点
3
主要终点
To assess and compare clinical outcome of treatment with homoeopathic medicine and allopathic medicine in uncomplicated UTI [symptom severity and duration using UTI Symptoms Assessment questionnaire (UTISA)]

研究概览

简要总结

Urinary tract infection (UTI) is among the most prevailing infectious diseases with a substantial financial burden on society. It is estimated that 150 million UTIs occur yearly world-wide, accounting for $6 billion in health care expenditure. In general, the treatment consists of hydration, relief of urinary tract obstruction (if the cause) and judicious use of antibiotics. The present state of microbial resistance development is alarming. Prudent use of available antibiotics is the option to delay the development of resistance and there is necessity of exploring other treatment options. Various studies support that homoeopathic treatment is equivalent in effectiveness to antibiotics for certain human infectious diseases. Homoeopathy can be promoted as the first line of treatment for common day to day infectious diseases. The emerging anti-microbial resistance (AMR) can be tackled with Homoeopathy as adjuvant therapy for infectious diseases. Homeopathy in addition to conventional prophylactic measures seems to be an effective, promising method for the prevention of recurrent UTI in patients with SCI. There is very scarce literature to show usefulness of Homoeopathy in UTI. Clinical study to observe the usefulness of Homoeopathy in symptomatic relief, prevention of secondary complications (e.g. pyelonephritis) and improvement of quality of life is warranted.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients of both sexes aged 18-60 years presenting with clinical signs and symptoms of uncomplicated UTI.
  • Any two or more from the following: (a) Dysuria &/or urinary frequency, or urinary urgency, &/or abdominal/suprapubic pain.
  • Patients who had not taken antimicrobials within the last 2 weeks.
  • Patients willing to give informed consent.

排除标准

  • Pregnant, breastfeeding women.
  • Patients presenting with signs and symptoms of complicated UTI (those arising in a setting of catheterization, instrumentation, urologic anatomic or functional abnormalities, stones, obstruction, immunosuppression, cancer, renal or hepatic disease.
  • 3.Known cases of uncontrolled diabetes, hypertension.
  • 4.Patients unable or unwilling to give informed consent.

结局指标

主要结局

To assess and compare clinical outcome of treatment with homoeopathic medicine and allopathic medicine in uncomplicated UTI [symptom severity and duration using UTI Symptoms Assessment questionnaire (UTISA)]

时间窗: Day 0, 3, 7, 10.

次要结局

  • 1. To compare the changes in quality of life in response to both treatment groups.(2. To compare the changes in urine culture after homoeopathic Vs. allopathic treatment (micro biological outcome).)

研究者

发起方
Central Council for Research in Homoeopathy
申办方类型
Government funding agency

研究点 (3)

Loading locations...

相似试验